Cite
MLA Citation
Robert L Coleman et al.. “O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma.” International journal of gynecological cancer, vol. 32, n.d., pp. A3–A4. http://access.bl.uk/ark:/81055/vdc_100170500640.0x000036